Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2016-03-28 | Ms. Lewent served as Chief Financial Officer of Merck, a pharmaceutical company, from 1990 until her retirement in 2007. Board Committees: Audit (Chair), Executive. 2015 total compensation for Ms. Lewent was $260,019. |
| 2017-03-27 | Ms. Lewent served as CFO of Merck. Board Committees: Audit (Chair), Executive. 2016 director compensation total $260,031. |
| 2018-03-28 | Ms. Lewent served as Chief Financial Officer of Merck. Board Committees: Audit (Chair), Executive. 2017 director compensation total $312,583. |
| 2019-03-28 | Ms. Lewent served as Chief Financial Officer of Merck, a pharmaceutical company, from 1990 until her retirement in 2007. Board Committees: Audit (Chair), Executive Director Qualifications: Independent Age: 70 Director since: 2011 |
| 2020-03-27 | Ms. Lewent served as Chief Financial Officer of Merck. Board Committees: Audit (Chair), Executive. Fees Earned or Paid in Cash: 125,000, Stock Awards: 190,066, Total: 315,066 |
| 2021-04-01 | Ms. Lewent served as CFO of Merck. Board Committees: Audit (Chair), Executive. 2020 compensation total $301,271. |
| 2022-03-31 | Ms. Lewent served as Chief Financial Officer of Merck. Board Committees: Audit (Chair), Executive. Total compensation: $315,184. |
| 2023-03-30 | Ms. Lewent served as Chief Financial Officer of Merck. Board Committees: Audit (Chair), Executive. Compensation: $345,162 |
| 2024-03-28 | Ms. Lewent served as Chief Financial Officer of Merck, a pharmaceutical company, from 1990 until her retirement in 2007. Board Committees: Audit (Chair), Executive Director Qualifications: Public company CFO, financial and accounting expertise, capital allocation, global business, and human capital management experience as the former CFO of Merck Principal Occupation: Retired; Formerly Executive Vice President & Chief Financial Officer, Merck & Co., Inc. Age: 75 Race: White Director since: 2011 Independent |
| Filing Date | Source Excerpt |
|---|---|
| 2018-04-10 | The chairpersons of each of the Audit, Compensation, and Nominating and Corporate Governance Committees, as well as the chairpersons of the Strategy and Finance Committee of the Board, which Committee consists of Ms. Lewent (Chair), Messrs. Casper, Sørensen and Sperling, and Dr. Jacks, and the Science and Technology Committee of the Board, which Committee consists of Drs. Jacks (Chair) and Harris, and Mr. Casper, receive additional compensation for their services in those positions. |
| 2019-04-09 | Judy C. Lewent Former Chief Financial Officer, Merck & Co., Inc. Strategy and Finance Summary Director Compensation Table Judy C. Lewent Fees Earned or Paid in Cash: $140,000 Stock Awards: $175,165 All Other Compensation: $16,090 Total: $331,255 Proxy Statement 2019 |
| 2020-04-07 | Judy C. Lewent Independent Former Chief Financial Officer, Merck & Co., Inc. Age: 71 Director since: 2008 Committees: Strategy and Finance (Chair) Summary director compensation table Total: $351,177 |
Data sourced from SEC filings. Last updated: 2025-08-30